Micaela A. Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Micaela A. Soares has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bruna Rodrigues Gontijo
Postgraduate Program in Health Sciences and Technologies, Faculty of Ceilândia, University of Brasília (UnB), Brasília-Federal District (DF), Brasília 72220-900, Brazil
1 shared publication - Calliandra Maria de Souza Silva
Postgraduate Program in Health Sciences and Technologies, Faculty of Ceilândia, University of Brasília (UnB), Brasília-Federal District (DF), Brasília 72220-900, Brazil
1 shared publication - Cristina Lemos Barbosa Furia
Universidade de Brasília, Brazil
1 shared publication - Dante Mafra Tourino Teixeira
Postgraduate Program in Health Sciences and Technologies, Faculty of Health Sciences and Technology, University of Brasilia (UnB), Brasilia-Federal District (DF), Brasilia 72220-900, Brazil
1 shared publication - Izabel Cristina Rodrigues da Silva
Postgraduate Program in Health Sciences and Technologies, Faculty of Ceilândia, University of Brasília (UnB), Brasília-Federal District (DF), Brasília 72220-900, Brazil
1 shared publication - Jamila Reis de Oliveira
Postgraduate Program in Health Sciences, University of Brasília (UnB), Ceilândia Campus, Brasília 72220-275, Brazil
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by MDPI AG in Proceedings
- Vol. 137 (1) , 64
PCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients
Introduction: PCSK9 encodes a protein that regulates cholesterol homeostasis by promoting degradation of the low-density lipoprotein receptor (LDLR), thereby increasing plasma LDL-cholesterol levels and influencing cardiovascular risk
- 2 March 2026
- Published by MDPI AG in Proceedings
- Vol. 137 (1) , 64
Open AccessPCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients
Introduction: PCSK9 encodes a protein that regulates cholesterol homeostasis by promoting degradation of the low-density lipoprotein receptor (LDLR), thereby increasing plasma LDL-cholesterol levels and influencing cardiovascular risk